Data Bridge Market Research analyses that the Africa Malaria Treatment Market was growing at a value of USD 500,416.09 Thousand in 2021 and is expected to reach a value of USD 817,078.98 Thousand and registering a CAGR of 6.4% from 2022 to 2028.
Industry Analysis
• Malaria is an infectious disease, which spreads through a bite of an infected female Anopheles mosquito, transferring parasites into the human body. Furthermore, these parasites lodge into liver cells, where they multiply and grow. They then move to red blood cells to reach a stage called merozoites. These merozoites grow inside the red cells and destroy them, which further cause symptoms such as fever, tiredness, vomiting, and headache. In addition, the drugs that are used to treat and prevent malarial infections are called antimalarial. There are different types of drugs, such as quinine, chloroquine, proguanil, mefloquine, pyrimethamine, and others, available in the market for the treatment of malarial infection.
• Africa malaria treatment market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the Africa malaria treatment market scenario, contact Data Bridge Market Research for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
Some of the key questions answered in this report:
1. At what growth rate will the market be projected to grow during the forecast 2028?
2. What will be the market value in the future?
3. Which region holds the largest share in the market?
4. Who are the major players operating in the market?
Africa Malaria Treatment Market Scope
Africa malaria treatment market is segmented into seven notable segments based on agent, type, treatment, drug type, route of administration, end user and distribution channel.
• On the basis of agent, the Africa malaria treatment market is segmented into Plasmodium Falciparum, P. Vivax, P. Ovale, P. Malariae, and P. Knowlelsi. In 2021, the Plasmodium Falciparum segment is expected to dominate the market due to its rapid transmission. Additionally, the climate condition and humidity of Sub-Saharan Africa enhance malaria transmission by plasmodium falciparum.
• On the basis of type, the Africa malaria treatment market is segmented into medication, vaccination, and others. In 2021, the medication segment is expected to dominate the market because it is cost-effective, easily accessible, and primary treatment for the malaria patient pool.
• On the basis of treatment type, the Africa malaria treatment market is segmented into suppressive treatment and radical treatment. In 2021, the suppressive treatment segment is expected to dominate the market because it is considered the primary and fundamental treatment. Moreover, the enormous demand for suppressive treatment worldwide acts as another driving factor for market growth.
• On the basis of drug type, the Africa malaria treatment market is segmented into branded and generics. In 2021, the generics segment is expected to dominate the market because it is cost-effective compared to branded drugs. The growing demand for generics drugs from low and middle-income countries is another driving factor for market growth.
• On the basis of route of administration, the Africa malaria treatment market is segmented into oral and parenteral. In 2021, the oral segment is expected to dominate the market because it is considered to be the first line of therapy. Moreover, the low manufacturing cost of tablets, capsules, and other orally administered drugs act as another driving factor for the market growth.
• On the basis of end user, the Africa malaria treatment market is segmented into hospitals, specialty clinics, home healthcare, and others. In 2021, the hospitals segment is expected to dominate the market because of the increased healthcare expenditure by hospitals on advanced medical treatment.
• On the basis of distribution channel, the Africa malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. In 2021, the direct tender segment is expected to dominate the market because of the surge in innovations and technologies, and the rising government funding is also propelling the market's growth.
Grab a sample copy of the report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=africa-m...
Africa Malaria Treatment Market Regional Analysis/Insights
Africa malaria treatment market is segmented into seven notable segments based on agent, type, treatment, drug type, route of administration, end user and distribution channel.
The countries covered in the global Africa Malaria Treatment Market report are
• Nigeria
• Democratic Republic of Congo
• Uganda
• Coste D’ Ivoire
• Niger
• Kenya
• Egypt
• South Africa
Competitive Landscape and Africa Malaria Treatment Market Share Analysis
The Africa malaria treatment market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Africa malaria treatment market.
Some of the major players operating in the Africa Malaria Treatment market are:
• Hikma Pharmaceuticals PLC
• Sun Pharmaceutical Industries Ltd.
• Zydus Cadila
• Cipla Inc.
• GlaxoSmithKline plc.
• Bliss GVS Pharma Ltd.
• MMV
• Novartis AG
• Taj Pharmaceuticals Limited
• Lupin Pharmaceuticals, Inc. (A Subsidiary of Lupin Limited)
• AJANTA PHARMA
• Strides Pharma Science Limited
• sanofi-aventis U.S. LLC (A Subsidiary of Sanofi)
• Viatris Inc.
Get Full Access of reports @ https://www.databridgemarketresearch.com/reports/africa-malaria-treatmen...
MAJOR TOC OF THE REPORT
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insights
Chapter Six: Africa Malaria Treatment Market by Product & Procedure type
Get TOC Details:
https://www.databridgemarketresearch.com/toc/?dbmr=africa-malaria-treatm...
Browse Related Reports @
Malaria Treatment Market
North America Malaria Treatment Market
Middle East and Africa Malaria Treatment Market
Asia-Pacific Malaria Treatment Market
Europe Malaria Treatment Market
About Us:-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:-
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com